These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 19669997)
1. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO). Herraiz T; Arán VJ; Guillén H Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors. Herraiz T; Guillén H Food Chem Toxicol; 2011 Aug; 49(8):1773-81. PubMed ID: 21554916 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to toxic pyridinium cations by monoamine oxidase (MAO) enzymes and its use to search for new MAO inhibitors and protective agents. Herraiz T J Enzyme Inhib Med Chem; 2012 Dec; 27(6):810-7. PubMed ID: 21992679 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs. Youngster SK; Sonsalla PK; Sieber BA; Heikkila RE J Pharmacol Exp Ther; 1989 Jun; 249(3):820-8. PubMed ID: 2786564 [TBL] [Abstract][Full Text] [Related]
5. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites. Itzhak Y; Mash D; Zhang SH; Stein I Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660 [TBL] [Abstract][Full Text] [Related]
6. Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone. Yoshihara S; Ohta S Arch Biochem Biophys; 1998 Dec; 360(1):93-8. PubMed ID: 9826433 [TBL] [Abstract][Full Text] [Related]
7. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives. Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109 [TBL] [Abstract][Full Text] [Related]
9. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A. Basma AN; Heikkila RE; Nicklas WJ; Giovanni A; Geller HM J Neurochem; 1990 Sep; 55(3):870-7. PubMed ID: 2384758 [TBL] [Abstract][Full Text] [Related]
10. N-methyltetrahydro-beta-carboline analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin are oxidized to neurotoxic beta-carbolinium cations by heme peroxidases. Herraiz T; Guillén H; Galisteo J Biochem Biophys Res Commun; 2007 Apr; 356(1):118-23. PubMed ID: 17346675 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalyzed oxidation of MPTP analogs. Youngster SK; Nicklas WJ; Heikkila RE J Pharmacol Exp Ther; 1989 Jun; 249(3):829-35. PubMed ID: 2786565 [TBL] [Abstract][Full Text] [Related]
12. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases. Singer TP; Salach JI; Castagnoli N; Trevor A Biochem J; 1986 May; 235(3):785-9. PubMed ID: 3489461 [TBL] [Abstract][Full Text] [Related]
13. Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B. Pretorius A; Ogunrombi MO; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP Bioorg Med Chem; 2008 Oct; 16(19):8813-7. PubMed ID: 18799315 [TBL] [Abstract][Full Text] [Related]
14. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline. Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors. Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910 [TBL] [Abstract][Full Text] [Related]
16. Biotransformation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes. Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW J Pharmacol Exp Ther; 1991 Aug; 258(2):594-600. PubMed ID: 1907660 [TBL] [Abstract][Full Text] [Related]
17. Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6. Herraiz T; Guillén H; Arán VJ; Idle JR; Gonzalez FJ Toxicol Appl Pharmacol; 2006 Nov; 216(3):387-98. PubMed ID: 16870220 [TBL] [Abstract][Full Text] [Related]
18. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B. Finnegan KT; Irwin I; Delanney LE; Langston JW J Pharmacol Exp Ther; 1995 May; 273(2):716-20. PubMed ID: 7752075 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine. Takamidoh H; Naoi M; Nagatsu T Neurosci Lett; 1987 Jan; 73(3):293-7. PubMed ID: 3494215 [TBL] [Abstract][Full Text] [Related]
20. Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes. Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW Glia; 1992; 5(1):48-55. PubMed ID: 1311704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]